Management of HBV in Liver Transplant Patients


The Post-Transplant Challenge: How to Prevent HBV Recurrence Keeping Sight of HDV Co-infection, Hepatocellular Carcinoma and Other Risk Factors

Thursday, December 16, 2021, 10:00 AM (Local time in Montreal)
Local time (Corresponding local time at your current location)

Overview

This will include clinical cases as examples, including details of when best to use hepatitis B immunoglobulin, when to use antiviral therapy, when to use screening testing and how to best interpret.

Learning Objectives

  1. When to test for hepatitis D
  2. What to do in the setting of positive test results
  3. How to best screen for HCC
  4. Awareness of national and international guidelines

Moderator
Manuel Rodriguez-Davalos
USA
Bio
Speaker
Emily Bethea
USA
Bio
Speaker
Patrizia Burra
Italy
Bio


Use the image below to promote this event (right-click to download)

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada